leadf
logo-loader
viewMotif Bio PLC

Motif Bio PLC trims board of five directors

“The resignations are in line with the proposals to minimise the company's costs and to preserve capital,” the company said

Motif Bio PLC -
Motif is looking to divest its biotech business

Motif Bio PLC (LON:MTFB, Nasdaq:MTFB) has trimmed down its board to three directors as it looks to preserve capital while looking to sell its biotech assets or winding down the business and becoming a cash shell.

As of last Friday, non-executive directors Craig Albanese, Charlotta Ginman, Zaki Hosny, Mary Lake Polan and Andrew Powell all offered their resignations and stood down from the board with immediate effect.

“The resignations are in line with the proposals to minimise the company's costs and to preserve capital,” Motif said. 

The AIM-listed company’s board is now made up of two executive directors, chief executive Graham Lumsden and chief financial officer Jonathan Gold, together with non-executive chairman Bruce Williams.

Last month, Motif shareholders voted to either wind the company down, or sell all or most of its existing business, assets and investments, which would result in it becoming a cash shell.

Quick facts: Motif Bio PLC

Price: 0.5 GBX

AIM:MTFB
Market: AIM
Market Cap: £3.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

GinsGlobal Managing Director sees Healthcare and Healthcare innovation as...

HANetf and GinsGlobal Index Funds' Managing Director Anthony Ginsberg joined Steve Darling from Proactive to share details about the success of their Healthcare Innovations ETF. Ginsberg discusses how COVID-19 had made a direct impact on that fund, especially in the telemedicine...

1 day, 3 hours ago

2 min read